Medical News |
- Depression treatment ‘should target emotional control’
- Cognitive impairments linked to mood episode recurrence risk
- Depression treatment ‘should target emotional control’
- Cognitive remediation may benefit youth with psychosis
- Cognitive impairments linked to mood episode recurrence risk
- Cognitive remediation may benefit youth with psychosis
- ATLAS holds up 10-year tamoxifen regime
- Risk factors revealed for anti-tuberculosis drug hepatotoxicity
- Risk factors revealed for anti-tuberculosis drug hepatotoxicity
- Microarray analysis ‘best test for prenatal diagnosis’
- ATLAS holds up 10-year tamoxifen regime
- Antimicrobial catheters do not significantly reduce UTI risk
- Thulium vapoenucleation well-tolerated for treating benign prostate obstruction
| Depression treatment ‘should target emotional control’ Posted: 10 Dec 2012 04:00 PM PST Being able to regulate emotions is a key driver of patients' improvement in symptoms when undergoing treatment for depression, German researchers have shown. |
| Cognitive impairments linked to mood episode recurrence risk Posted: 10 Dec 2012 04:00 PM PST Cognitive impairments are associated with an increased risk for mood episode recurrence in euthymic patients with bipolar disorder, researchers report. |
| Depression treatment ‘should target emotional control’ Posted: 10 Dec 2012 04:00 PM PST Being able to regulate emotions is a key driver of patients' improvement in symptoms when undergoing treatment for depression, German researchers have shown. |
| Cognitive remediation may benefit youth with psychosis Posted: 10 Dec 2012 04:00 PM PST Results from a Swiss study suggest that computer-assisted cognitive remediation may help improve certain aspects of cognition in adolescent patients with or at risk for psychosis. |
| Cognitive impairments linked to mood episode recurrence risk Posted: 10 Dec 2012 04:00 PM PST Cognitive impairments are associated with an increased risk for mood episode recurrence in euthymic patients with bipolar disorder, researchers report. |
| Cognitive remediation may benefit youth with psychosis Posted: 10 Dec 2012 04:00 PM PST Results from a Swiss study suggest that computer-assisted cognitive remediation may help improve certain aspects of cognition in adolescent patients with or at risk for psychosis. |
| ATLAS holds up 10-year tamoxifen regime Posted: 09 Dec 2012 04:00 PM PST Results from the ATLAS study indicate that women with estrogen receptor-positive breast cancer should consider taking tamoxifen for up to 10 years after diagnosis. |
| Risk factors revealed for anti-tuberculosis drug hepatotoxicity Posted: 09 Dec 2012 04:00 PM PST The risk for hepatotoxicity among patients treated with anti-tuberculosis drugs is affected by gender, ethnicity, and the presence of genetic polymorphisms, say Argentinean researchers. |
| Risk factors revealed for anti-tuberculosis drug hepatotoxicity Posted: 09 Dec 2012 04:00 PM PST The risk for hepatotoxicity among patients treated with anti-tuberculosis drugs is affected by gender, ethnicity, and the presence of genetic polymorphisms, say Argentinean researchers. |
| Microarray analysis ‘best test for prenatal diagnosis’ Posted: 09 Dec 2012 04:00 PM PST Chromosomal microarray analysis is able to identify significantly more clinically relevant information for prenatal diagnosis than is karyotyping, and is equally able to highlight aneuploidies and unbalanced rearrangements, US study findings suggest. |
| ATLAS holds up 10-year tamoxifen regime Posted: 09 Dec 2012 04:00 PM PST Results from the ATLAS study indicate that women with estrogen receptor-positive breast cancer should consider taking tamoxifen for up to 10 years after diagnosis. |
| Antimicrobial catheters do not significantly reduce UTI risk Posted: 09 Dec 2012 04:00 PM PST Silver alloy-coated antimicrobial catheters do not significantly reduce the risk for catheter-associated urinary tract infection compared with standard catheters in adult hospital patients requiring short-term catheterization, show UK study results. |
| Thulium vapoenucleation well-tolerated for treating benign prostate obstruction Posted: 09 Dec 2012 04:00 PM PST Treating benign prostate obstruction with thulium vapoenucleation of the prostate is well-tolerated and effective and leads to a low incidence of perioperative complications, according to recent study findings. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment